APA (7th ed.) Citation

SS, K., JR, C., HK, T., CG, G., KJ, W., E, K., . . . M, S. (2022). Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza and other respiratory viruses, 16(6), 975. https://doi.org/10.1111/irv.13029

Chicago Style (17th ed.) Citation

SS, Kim, et al. "Effectiveness of Two and Three MRNA COVID-19 Vaccine Doses Against Omicron- and Delta-Related Outpatient Illness Among Adults, October 2021-February 2022." Influenza and Other Respiratory Viruses 16, no. 6 (2022): 975. https://doi.org/10.1111/irv.13029.

MLA (9th ed.) Citation

SS, Kim, et al. "Effectiveness of Two and Three MRNA COVID-19 Vaccine Doses Against Omicron- and Delta-Related Outpatient Illness Among Adults, October 2021-February 2022." Influenza and Other Respiratory Viruses, vol. 16, no. 6, 2022, p. 975, https://doi.org/10.1111/irv.13029.